Literature DB >> 2745436

Evidence for positive and negative regulatory elements in the 5'-flanking sequence of the mouse sparc (osteonectin) gene.

S Nomura1, S Hashmi, J H McVey, J Ham, M Parker, B L Hogan.   

Abstract

We have investigated the role of 5'-flanking DNA sequences in regulating the expression of the murine Sparc (osteonectin) gene in parietal endoderm cells and in F9 embryonal carcinoma cells induced to differentiate into parietal endoderm with retinoic acid and cyclic AMP. Varying lengths of flanking sequences extending up to 3.0 kilobase pairs 5' of the transcription initiation site were linked to the bacterial chloramphenicol transacetylase gene in the Bluescript M13- vector. The constructs were tested in transient assays, using a beta-galactosidase plasmid as a transfection control. Sequences between 78 and 169 base pairs upstream of the cap site are the minimum required for cell-type specific promoter activity; this region is dominated by two oligopurine/oligopyrimidine stretches or "GAGA" boxes and is highly conserved between the mouse and bovine genes. Addition of the sequence between -169 and -449, which includes part or all of a third GAGA box, results in increased parietal endoderm specific transcription, up to a maximum of 6.3-fold higher than in undifferentiated F9 cells. Further addition of sequences between -449 and -638 markedly reduces promoter activity in both cell types but parietal endoderm-specific activity is restored in constructs containing 2.2 and 3.0 kilobase pairs of flanking DNA. In addition, we have identified sequences related to the consensus sequence for steroid response elements, one of which is able to confer progesterone-enhanced transcription when tested with a heterologous promoter in steroid responsive cells. These results suggest that negative and positive elements normally interact to regulate the temporal and tissue-specific patterns of Sparc gene transcription seen in vivo.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2745436

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  CpG methylation of an endogenous retroviral enhancer inhibits transcription factor binding and activity.

Authors:  B T Lamb; K Satyamoorthy; L Li; D Solter; C C Howe
Journal:  Gene Expr       Date:  1991

2.  Binding of a nuclear protein to the rat growth hormone silencer element.

Authors:  R J Roy; P Gosselin; M J Anzivino; D D Moore; S L Guérin
Journal:  Nucleic Acids Res       Date:  1992-02-11       Impact factor: 16.971

3.  miR-29 suppression of osteonectin in osteoblasts: regulation during differentiation and by canonical Wnt signaling.

Authors:  Kristina Kapinas; Catherine B Kessler; Anne M Delany
Journal:  J Cell Biochem       Date:  2009-09-01       Impact factor: 4.429

4.  Identification of an intronic enhancer that nullifies upstream repression of SPARC gene expression.

Authors:  K Satyamoorthy; S J Samulewicz; L D Thornburg; A Basu; C C Howe
Journal:  Nucleic Acids Res       Date:  1997-08-01       Impact factor: 16.971

5.  The inflammatory tumor microenvironment, epithelial mesenchymal transition and lung carcinogenesis.

Authors:  Eileen L Heinrich; Tonya C Walser; Kostyantyn Krysan; Elvira L Liclican; Jeanette L Grant; Nicole L Rodriguez; Steven M Dubinett
Journal:  Cancer Microenviron       Date:  2011-09-16

6.  Transcriptional promoter of the human alpha 1(V) collagen gene (COL5A1).

Authors:  S Lee; D S Greenspan
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

7.  A regulatory element is characterized by purine-mediated and cell-type-specific gene transcription.

Authors:  M J Walsh; A Sanchez-Pozo; N S Leleiko
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

8.  Osteonectin/SPARC polymorphisms in Caucasian men with idiopathic osteoporosis.

Authors:  A M Delany; D J McMahon; J S Powell; D A Greenberg; E S Kurland
Journal:  Osteoporos Int       Date:  2007-12-15       Impact factor: 4.507

9.  Co-Targeting Prostate Cancer Epithelium and Bone Stroma by Human Osteonectin-Promoter-Mediated Suicide Gene Therapy Effectively Inhibits Androgen-Independent Prostate Cancer Growth.

Authors:  Shian-Ying Sung; Junn-Liang Chang; Kuan-Chou Chen; Shauh-Der Yeh; Yun-Ru Liu; Yen-Hao Su; Chia-Yen Hsueh; Leland W K Chung; Chia-Ling Hsieh
Journal:  PLoS One       Date:  2016-04-07       Impact factor: 3.240

10.  SPARC and thrombospondin genes are repressed by the c-jun oncogene in rat embryo fibroblasts.

Authors:  A Mettouchi; F Cabon; N Montreau; P Vernier; G Mercier; D Blangy; H Tricoire; P Vigier; B Binétruy
Journal:  EMBO J       Date:  1994-12-01       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.